Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             231 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 295 Accumulation of 53BP1 in circulating tumor cells during treatment with eribulin identifies chemotherapy-responsive metastatic breast cancer patients Schochter, Fabienne

30 S4 p. A98
artikel
2 393 A clinical audit of molar pregnancies and gestational trophoblastic neoplasia cases over 1yr in a tertiary care hospital of Eastern India with respect to the incidence of disease, factors related to etiopathogenesis, diagnosis and management Banerjee, Swarnabindu

30 S4 p. A99-A100
artikel
3 195 A clinical study on the application of 3D-printing minimally invasive-guided template in brachytherapy of patients with locally advanced cervical cancer Yuan, Xiangkun

30 S4 p. A6-A7
artikel
4 437 Adrenal incidentalomas in gynaecology oncology surgical patients: timely investigation and management avoiding undue delays to oncological surgery Grant, Marie-Therese

30 S4 p. A53
artikel
5 527 Analysis of uterine lavage for early ovarian cancer detection Zilovic, Diana

30 S4 p. A113-A114
artikel
6 165 An audit of the use of vaginal brachytherapy in endometrial cancers Ilangovan, Bhargavi

30 S4 p. A30-A31
artikel
7 310 A new proposal for the clinical classification of vulvar lichen sclerosus: an observational prospective study Boero, Veronica

30 S4 p. A24-A25
artikel
8 606 Angiomyofibroblastoma vulvar: case report and literature review Buitrago, Sandra Marcela

30 S4 p. A132
artikel
9 609 Angiomyofibroblastoma vulvar: case report and literature review Buitrago, Sandra Marcela

30 S4 p. A133
artikel
10 585 A pilot study for the validation of sentinel lymph node biopsy with indocyanine green fluorescence method in early endometrial cancer at Fundación Jiménez Díaz university hospital Villayzan, José García

30 S4 p. A119-A120
artikel
11 622 Applicability of duke activity scale index (DASI) in perioperative prediction of postoperative complications for gynaeoncology patients Sevinyan, Lusine

30 S4 p. A134-A135
artikel
12 596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36) Glasspool, Rosalind

30 S4 p. A127-A128
artikel
13 316 ‘Are there limits to curative treatments?’ – The impact of chemo-radiation in cervical cancer patients Alpoim, Tiago

30 S4 p. A11
artikel
14 551 A retrospective study of sternal metastases in breast cancer Ghomari, Cherifa Fazila

30 S4 p. A2
artikel
15 595 Assessing trends in stage and outcomes of uterine cervix cancer in an opportunistic screening setting Cruz Lugarinho, Priscila Tavares

30 S4 p. A116
artikel
16 369 A systematic review to identify and assess the mental health sequalae amongst women with endometriosis with or without chronic pelvic pain (THE ELEMI PROJECT) Hapangama, Dharani

30 S4 p. A52-A53
artikel
17 194 Ataxia-teleangiectasia followed up in a hereditary gynaecological cancer unit of a tertiary hospital Veiga-Fernández, Amanda

30 S4 p. A91-A92
artikel
18 505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study Gaba, Faiza

30 S4 p. A93-A94
artikel
19 Author index
30 S4 p. 136-141
artikel
20 556 Axillary lymphadenectomy vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis Petousis, Stamatios

30 S4 p. A2-A3
artikel
21 554 Biopsar study: ultrasound-guided preoperative biopsy to assess histology of sarcoma-suspicious uterine tumors. a new study protocol Petousis, Stamatios

30 S4 p. A113
artikel
22 261 BRCA1/2 mutations predict better survival in high-grade endometrioid endometrial cancer Dai, Yibo

30 S4 p. A32
artikel
23 229 Breast cancer patients at increased risk of developing type II endometrial cancer; relative and absolute risk estimation and implications for genetic counselling Laios, Alexandros

30 S4 p. A92
artikel
24 411 Cancer cell stemness and collagen regulators of stemness in uterine serous carcinoma (USC) mirror ovarian serous cancer (OSC) cell stemness: evidence emerging from ARK1-USC Hanauske-Abel, Hartmut

30 S4 p. A41
artikel
25 197 Can D-dimers and fibrinogen aid in the diagnosis of ovarian cancer? Mckendry, Kate

30 S4 p. A57
artikel
26 139 Centre of hereditary breast and ovarian cancer at charité – who presents for counseling and why? Helms, Malina

30 S4 p. A109
artikel
27 193 Cervical oncological cytologies’s (PAP test) evaluation of the riverine women from rivers tapajós and cupari (Pará – Brazil) Lima Ferrero, Maria Vitoria

30 S4 p. A6
artikel
28 383 Changes in the proteome of cervicovaginal fluid during HPV infection in hpv-vaccinated women Iurova, Mariia

30 S4 p. A15-A16
artikel
29 320 Charlson comorbidity index as a factor impacting survival among ovarian cancer patients – results from a systematic review Asthana, Smita

30 S4 p. A66-A67
artikel
30 441 Chemotherapy response score: correlation with preoperative serological and radiological assessment of response and clinical implications in ovarian cancer patients Ramspott, Jan Philipp

30 S4 p. A83
artikel
31 599 Circulating tumour cells in breast and ovarian cancer: size-based isolation and ex vivo expansion Mohamed, Bashir

30 S4 p. A131-A132
artikel
32 314 Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study Zhu, Chenchen

30 S4 p. A66
artikel
33 576 Clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma of the cervix, a local study Yu, Marilou

30 S4 p. A114
artikel
34 345 Clinical parameters predicting risk of concurrent invasive carcinoma and high-risk carcinoma in patients with endometrial intraepithelial neoplasia Orhan, Nazlı

30 S4 p. A36
artikel
35 615 Clinic-pathological features of mixed endometrial carcinoma; evaluation of 29 patients in a single tertiary center Sucu, Mete

30 S4 p. A122-A123
artikel
36 509 Combitec: multicentric retrospective study on sentinel lymph node detection by combined icg + 99MTC versus exclusive icg in endometrial cancer Conesa, Vicente Bebia

30 S4 p. A44
artikel
37 382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study Zander, Lena

30 S4 p. A1
artikel
38 608 Comparison of topical treatment of cervical squamous intraepithelial lesionswith imiquimod with standard excisional technique using LLETZ: a randomized controlled trial Cokan, Andrej

30 S4 p. A117
artikel
39 330 Complete surgical cytoreduction remains pivotal in achieving better survival outcomes in patients with advanced ovarian cancer with a BRCA1/2 germline mutation in the pre-parp inhibitor ERA Otify, Mohamed

30 S4 p. A67
artikel
40 525 Concurrent chemoradiotherapy followed by surgery for cervical cancer: a multicenter retrospective study of 126 cases Fouad, Asmàa

30 S4 p. A22-A23
artikel
41 108 Conditional relative survival of ovarian cancer : a korean national cancer registry study Bae, Jaeman

30 S4 p. A55-A56
artikel
42 78 Contralateral non-sentinel node metastasis in early primary vulvar cancer women with positive unilateral sentinel node Winarno, Andreas Suhartoyo

30 S4 p. A102
artikel
43 257 Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage ovarian cancer in Australia, South Korea and Taiwan Chou, Hung-Hsueh

30 S4 p. A59-A60
artikel
44 258 Design and validation of a recurrence risk predicting score in early stage cervical cancer after radical hysterectomy Manzour, Nabil

30 S4 p. A8
artikel
45 619 Detecting cervical dysplasia with folate receptor-mediated detection staining agent Roškar, Luka

30 S4 p. A118
artikel
46 443 Detection of the sentinel lymph node by ecoguided myometrial injection (TUMIR) of radiotracer versus hybrid tracer (RADIOTRACER-ICG) in patients with intermediate/high risk endometrial cancer Agustí, Núria

30 S4 p. A41-A42
artikel
47 54 Diagnostic accuracy of serum insulin-like growth factor binding protein 2 for ovarian cancer Aditya Prayudi, Pande Kadek

30 S4 p. A54
artikel
48 311 Diagnostic value of HE4, CA-125, roma and cph-i for preoperative assessment of ovarian tumors Diéguez, Núria Carreras

30 S4 p. A25-A26
artikel
49 256 Differences in immune-related adverse events between vulvovaginal vs. cutaneous melanoma: a retrospective cohort study Naderi-Azad, Sheida

30 S4 p. A104
artikel
50 154 Disease-free survival in early-stage cervical cancer: comparison of laparoscopic versus open surgery in a tertiary centre Veiga-Fernández, Amanda

30 S4 p. A5-A6
artikel
51 86 3D-printed multi-channel vaginal applicator for brachytherapy in gynecological cancer Logar, Helena

30 S4 p. A102-A103
artikel
52 552 Dual cervical and fundal injection in endometrial cancer Gorostidi, Mikel

30 S4 p. A46
artikel
53 577 Early salpingectomy (tubectomy) with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy to improve quality of life in women with a BRCA1/2 pathogenic variant (tuba study): a prospective multicenter preference trial Steenbeek, Miranda P

30 S4 p. A128-A129
artikel
54 589 Early stage, low grade endometrial adenocarcinoma in reproductive aged women. an evaluation of patient perspectives of diagnosis, treatment decision making, management, fertility and survivorship: a qualitative study Roman, Alina

30 S4 p. A120-A121
artikel
55 498 Edmond: a feasibility study of elemental diet as an alternative to parenteral nutrition for ovarian cancer patients with inoperable malignant bowel obstruction Michael, Agnieszka

30 S4 p. A85
artikel
56 476 Effectiveness of photodynamic therapy in lichen sclerosus with neoplastic background Bizoń-Szpernalowska, Magdalena

30 S4 p. A97
artikel
57 611 Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: a systematic review of clinical trials Pilger, Taynara Louisi

30 S4 p. A114
artikel
58 326 Effects of local laser treatment on vulvovaginal atrophy for women with breast cancer: a prospective study with long-term follow-up Veron, Lucie

30 S4 p. A96
artikel
59 347 Efficacy and safety of niraparib in older patients (PTS) with advanced ovarian cancer (OC): results from the prima/ENGOT-OV26/GOG-3012 trial Dahlstrand, Hanna

30 S4 p. A69-A70
artikel
60 288 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk HPV+ patients: results of different studies Gaslain, Yann

30 S4 p. A10
artikel
61 285 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in HPV+ women older than 40 years: sub-analysis of paloma clinical trial Gaslain, Yann

30 S4 p. A9
artikel
62 388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients Peen, Ulla

30 S4 p. A90-A91
artikel
63 364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study Braicu, Elena Ioana

30 S4 p. A70-A71
artikel
64 416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer Kulbe, Hagen

30 S4 p. A79
artikel
65 357 Endometrial biopsies: for whom and when? Temiz, Bilal Esat

30 S4 p. A36-A37
artikel
66 492 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern Parpinel, Giulia

30 S4 p. A43
artikel
67 387 ENGOT-EN6/GOG-3031/NSGO-RUBY: a phase 3, randomised, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel versus placebo + carboplatin-paclitaxel in recurrent or primary advanced endometrial cancer (EC) Mirza, Mansoor R

30 S4 p. A112
artikel
68 559 Enhanced recovery after surgery (ERAS) for para-aortic lymphadenectomy-a new trend to consider? Masquin, Isabelle

30 S4 p. A24
artikel
69 575 Epidemiology of ovarian cancer in kazakhstan (2013–2018) Kaidarova, Dilyara

30 S4 p. A126
artikel
70 439 Epidemiology of ovarian cancer in kazakhstan (2013–2018) Kaidarova, Dilyara

30 S4 p. A82
artikel
71 200 Evaluation of a proposed trastuzumab biosimilar compared with trastuzumab in neoadjuvant breast cancer treatment Vitorino, Marina

30 S4 p. A1
artikel
72 584 Evaluation of micro-RNA expression in cytological smears in women with low grade squamous intraepithelial lesions Prisyazhnaya, Tatyana

30 S4 p. A118
artikel
73 159 Evaluation of psychological distress and desire for psychosocial support in gynaecological cancer patients using the QSC-R10 Rudolph, Katharina

30 S4 p. A96
artikel
74 111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer Yao, Shih-Ern

30 S4 p. A56
artikel
75 366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer Lorusso, Domenica

30 S4 p. A71-A72
artikel
76 532 Fertility and pregnancy outcomes after fertility-sparing treatment in ovarian cancer patients Sorbi, Flavia

30 S4 p. A87
artikel
77 558 Fertility-sparing treatment for early stage cervical cancer: a single center experience with conization and nodal evaluation Martinelli, Fabio

30 S4 p. A48-A49
artikel
78 227 Fertility-sparing treatment in advanced borderline ovarian tumors. an analysis from the mito14 study database Falcone, Francesca

30 S4 p. A46-A47
artikel
79 423 Fibronectin and periostin as prognostic markers in ovarian cancer Kujawa, Katarzyna A

30 S4 p. A80-A81
artikel
80 418 First real-world hematologic adverse events experience with niraparib in advanced ovarian cancer Wang, Junjian

30 S4 p. A79-A80
artikel
81 444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer Cunnea, Paula

30 S4 p. A98-A99
artikel
82 428 Genomic instability metric concordance between oncoscan™, cytosnp and an fda-approved HRD test Cristescu, Razvan

30 S4 p. A130-A131
artikel
83 242 #Goasco20: success of a new twitter hashtag to promote gynaecological oncology specific information during asco 2020 virtual annual meeting Bhandoria, Geetu

30 S4 p. A50-A51
artikel
84 278 Gynaecologic and non-gynaecologic tumors metastatic to the ovaries Ziyadova, Gunel

30 S4 p. A51-A52
artikel
85 491 Have we improved uterine serous carcinomas management the last two decades? A single center experience Liontos, Michail

30 S4 p. A43
artikel
86 203 High expression of nanog and CRY1 is involved with tumor progression and poor prognosis in patients with cervical cancer Han, Gwan Hee

30 S4 p. A7
artikel
87 425 Hipec in ovarian cancer: the first case-control study in mexican patients Medina-Castro, Juan Manuel

30 S4 p. A81
artikel
88 431 Histopathological results after risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: single center experience Ehmann, Sarah

30 S4 p. A81-A82
artikel
89 493 How to reconstruct an open abdominal wall after necrotizing fasciitis: surgical management in difficult cases Aker, Seda Sahin

30 S4 p. A97-A98
artikel
90 445 Impact of age on cancer specific survival in patients with locally advanced cervical cancer Leon, David Cantu-de

30 S4 p. A17-A18
artikel
91 44 Impact of cervical cancer on quality of life and sexual functioning of Filipino patients who underwent definitive chemoradiation in the university of Santo Tomas hospital, manila, philippines Adajar, Erika Lourdes

30 S4 p. A95
artikel
92 594 Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study Sundar, Sudha S

30 S4 p. A123-A124
artikel
93 360 Impact of treatment modality on survival of figo stage IIB cervical cancer: a propensity-score matching analysis based on impact of treatment modality on survival of figo stage iib cervical cancer: a propensity-score matching analysis based on surveillance, epidemiology, and end results database Tu, Hua

30 S4 p. A13-A14
artikel
94 513 Impact of tumour-free margin and lymph node ratio on oncologic outcomes in vulvar cancer- a single institute experience Kalita, Chinmoyee

30 S4 p. A107
artikel
95 43 Implementation, practise and experiences of an international online multidisciplinary tumour board (IMDTB) with a cancer centre in northwest region of cameroon Hentsch, Sebastian

30 S4 p. A108-A109
artikel
96 485 Incidence of sexual dysfunction among cervical cancer patients in a tertiary medical center treated with chemoradiation from june to december 2019 Tubungbanua, Thalia

30 S4 p. A20
artikel
97 601 Increased institutional surgical experience in robot-assisted radical hysterectomy for early stage cervical cancer reduces recurrence rate. results from a nationwide study Ekdahl, Linnea

30 S4 p. A116
artikel
98 359 Induction chemotherapy for locally advanced cervical cancer – yay or nay? Simões, Pedro

30 S4 p. A12-A13
artikel
99 149 Influence of initial volume of cervical cancer on achieving the recommended brachytherapy dose at target volumes Tomasevic, Aleksandar

30 S4 p. A4-A5
artikel
100 453 Intra-tumoural electro-chemotherapy (ECT) with bleomycin for palliation of cutaneous recurrence in gynaecological malignancy Rundle, Stuart

30 S4 p. A105
artikel
101 79 Is primary chemoradiation a better treatment? A retrospective study of early stage node-positive cervical cancer Zhang, Nan

30 S4 p. A4
artikel
102 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study Gonzalez-Martin, Antonio

30 S4 p. A64-A65
artikel
103 73 Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy Cagetti, Leonel Varela

30 S4 p. A3
artikel
104 487 Liquid biopsy for diagnosing ovarian cancer- quantification of cell-free DNA and p53 mutational analysis Rajaram, Shalini

30 S4 p. A84
artikel
105 488 Local and systemic changes associated with the innate immune response and immunoregulatory mechanisms responsible for the establishment and progression of invasive cervical carcinoma Kurmyshkina, Olga

30 S4 p. A20-A21
artikel
106 520 Long term follow up after diagnosis of gestational trophoblastic disease Freitas, Pedro Corvelo

30 S4 p. A102
artikel
107 607 Long-term results of neoadjuvant dose-dense platinum-based chemotherapy in patients with locally advanced cervical cancer Smirnova, Olga

30 S4 p. A117
artikel
108 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study Colombo, Nicoletta

30 S4 p. A76-A77
artikel
109 470 Malignant ovarian tumors in pregnancy: a case series Azimi, Helena

30 S4 p. A84
artikel
110 395 Menopausal symptoms and sexual disorders in epithelial ovarian cancer survivors, a gineco vivrovaire2 study Joly, Florence

30 S4 p. A97
artikel
111 434 Metastatic postmolar choriocarcinoma of the skin Dajao, Michelle Lureineil

30 S4 p. A100-A101
artikel
112 500 Metformin as a preventive and therapeutic modality in endometrial cancer: a systematic review and meta-analysis of randomized control trials Prodromidou, Anastasia

30 S4 p. A44
artikel
113 255 Mirrors trial: minimally invasive robotic surgery, role in optimal debulking ovarian cancer, recovery & survival Uwins, Christina

30 S4 p. A111-A112
artikel
114 597 Mismatch repair protein expression defects in endometrioid endometrial adenocarcinoma Brincat, Mark

30 S4 p. A121
artikel
115 378 Mucoadhesive bilayer vaginal tablet as a potential adjuvant treatment for cervical cancer Zainol Abidin, Ismin Izwani

30 S4 p. A15
artikel
116 588 Neoadjuvant chemotherapy or first line debulking surgery in advanced ovarian cancers Chekman, Chemseddine

30 S4 p. A126-A127
artikel
117 422 New challenges in the management and follow-up of molar pregnancy Copos, Anca

30 S4 p. A100
artikel
118 469 New variant of reconstructive surgery for advanced vulvar cancer treatment Bubliieva, Olha

30 S4 p. A105
artikel
119 571 Niraparib in patients with newly diagnosed advanced ovarian brcam cancer: a post hoc analysis of the prima/engot-ov26/gog-3012 trial Korach, Jacob

30 S4 p. A125-A126
artikel
120 510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial Cartwright, Douglas

30 S4 p. A85-A86
artikel
121 296 Non-surgical management of malignant bowel obstruction in advanced ovarian cancer patients – a systematic review and meta-analysis Idaikkadar, Praveena

30 S4 p. A64
artikel
122 550 Novel 3D model systems to assess heterogeneity in response to platinum therapy in high grade serous ovarian cancer Ploski, Jennifer

30 S4 p. A99
artikel
123 71 Omitting lymphadenectomy in obese endometrial cancer patients undergoing sentinel lymph node mapping: when more is less Kogan, Liron

30 S4 p. A28-A29
artikel
124 543 Oncological and fertility outcomes after vaginal radical trachelectomy: single centre retrospective analysis Predanič, Iza Drobne

30 S4 p. A48
artikel
125 548 Oncological outcome of sentinel lymph node mapping or comprehensive surgical staging in patients with node-negative intermediate-risk endometrial cancer Siegenthaler, Franziska

30 S4 p. A45
artikel
126 318 One-step nucleic acid amplification (OSNA): a big ‘step’ towards a more accurate intra-operative assessment of sentinel lymph node status for early stage endometrial and cervical cancer? Tranoulis, Anastasios

30 S4 p. A26-A27
artikel
127 247 Optimising prediction accuracy of complete cytoreduction for high grade serous advanced ovarian cancer patients using nearest-neighbor models Laios, Alexandros

30 S4 p. A58-A59
artikel
128 506 Oral metronomic cyclophosphamide in recurrent ovarian cancer: a single centre experience Attianese, Daniela

30 S4 p. A85
artikel
129 564 Outcome of fertility sparing surgery in cervical cancer, a national study in Spain: cefer study Ibanez, Blanca Gil

30 S4 p. A49
artikel
130 521 PAP smear screening among female patients of the ibn rochd university hospital center: a cross sectional survey Fouad, Asmàa

30 S4 p. A94-A95
artikel
131 294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial Mäenpää, Johanna

30 S4 p. A63-A64
artikel
132 386 Patient-reported outcomes (PROS) in the garnet trial in patients (PTS) with advanced or recurrent mismatch repair deficient/microsatelite instability-high (DMMR/MSI-H) endometrial cancer (EC) treated with dostarlimab Kristeleit, Rebecca

30 S4 p. A40-A41
artikel
133 204 Performance and diagnostic accuracy of human papillomavirus testing on urine and self-collected vaginal samples in a referral population Cho, Hyun-Woong

30 S4 p. A7
artikel
134 47 Performance of cone biopsy excision for treatment of cervical intraepithelial neoplasia Sanad, Ahmad

30 S4 p. A91
artikel
135 557 Peritoneal cancer index (PCI) as a predictor of completeness of cytoreduction at primary and interval debulking surgery in advanced ovarian cancer Fagan, Paula

30 S4 p. A88-A89
artikel
136 610 Peritoneal carcinomatosis index as a predictor of cytoreductive outcomes in patients with advanced ovarian cancer Yakovleva, Maria

30 S4 p. A128
artikel
137 518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers Banerjee, Susana

30 S4 p. A86-A87
artikel
138 362 Phase-specific and lifetime costs of cervical and endometrial cancer among commercially insured patients in the United States Shah, Ruchitbhai

30 S4 p. A37-A38
artikel
139 403 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-OV50/GOG-329/INNOVATE-3 Vergote, Ignace B

30 S4 p. A113
artikel
140 401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention Gaba, Faiza

30 S4 p. A93
artikel
141 565 Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the dutch gynecological oncology audit (DGOA) Tewarie, Nishita Baldewpersad

30 S4 p. A89
artikel
142 623 P-possum vs ACS–NSQIP: patient understanding of post-operative risks and shared decision Sevinyan, Lusine

30 S4 p. A135
artikel
143 613 Predicting lymphedema associated with lymph node dissection in patients who undergo surgery for endometrial cancer: role of demographic and clinical characteristics Shokri, Nazila

30 S4 p. A122
artikel
144 533 Predictive role of radiomic for post-operative complications of lymphadenectomy in ec patients Magni, Francesco

30 S4 p. A44-A45
artikel
145 230 Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer (ANNIE): a multicenter, single-arm, phase 2 trial Liu, Guochen

30 S4 p. A58
artikel
146 553 Preoperative brachytherapy followed by laparoscopic hysterectomy: a new option to consider for early stages cervical cancer in the light of the LACC trial results Beyer, Clemence

30 S4 p. A23
artikel
147 168 Preoperative evaluation of lipid markers of malignant epithelial ovarian tumors Iurova, Mariia

30 S4 p. A56-A57
artikel
148 430 Preoperative measurement of tumor volume in early cervical cancer. is it reliable? Boria, Felix

30 S4 p. A16-A17
artikel
149 337 Primary imiquimod treatment versus surgery for vulvar intraepithelial neoplasia – PITVIN study. Baseline Results of a Randomized Clinical Trial Trutnovsky, Gerda

30 S4 p. A108
artikel
150 298 Prognostic factors for localized uterine carcinosarcoma – 18 years of real-world practice of a portuguese cancer centre Bexiga, Catarina

30 S4 p. A34-A35
artikel
151 209 Prognostic factors related to recurrence and survival of ­early stage vulvar squamous cell carcinoma Wang, Yun

30 S4 p. A103
artikel
152 583 Prognostic impact of serum inflammatory biomarkers combined with il-6 expression in cervical cancer patients Domenici, Lavinia

30 S4 p. A114-A115
artikel
153 486 Prognostic value of pet-ct scan on survival outcomes of advanced-staged ovarian cancer patients treated with neoadjuvant chemotherapy: a prospective study Petousis, Stamatios

30 S4 p. A27
artikel
154 413 Prognostic value of the tumor infiltrating lymphocytes and the neutrophil-to-lymphocyte ratio in patients with advanced ovarian cancer Álvarez-Abril, Beatriz

30 S4 p. A78-A79
artikel
155 93 Prophylactic human papillomavirus hpv vaccination to prevent recurrence of cervical intraepithelial neoplasia : a meta-analysis Bartels, Helena

30 S4 p. A91
artikel
156 468 Racial disparities in patients with covid-19 infection and gynecologic malignancy Lara, Olivia

30 S4 p. A54
artikel
157 327 Radical hysterectomy in early cervical cancer: characteristics and outcomes of a large-controlled european population Boria, Felix

30 S4 p. A11
artikel
158 306 Rationale and evidence for emerging antibody-drug conjugates in gynecological cancers: effect of online education on clinician knowledge Fisher, Geoff

30 S4 p. A10-A11
artikel
159 287 Real-life efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk hpv patients: interim analysis Gaslain, Yann

30 S4 p. A9-A10
artikel
160 405 Real-life response to standard of care in advanced ovarian cancer – an observational multi-national cohort study (RESPONSE) Marth, Christian

30 S4 p. A77-A78
artikel
161 281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients Salarich, Andrea Plaja

30 S4 p. A60-A61
artikel
162 361 Real-world healthcare costs by line of therapy among newly diagnosed cervical cancer patients and cervical cancer patients newly initiating systemic therapies Kebede, Nehemiah

30 S4 p. A14
artikel
163 374 Real world prognostic relevance of residual disease and other clinical factors on the progression of disease and death in patients with advanced ovarian cancer in the US Chase, Dana

30 S4 p. A74-A75
artikel
164 379 Real world retrospective study of patients with epithelial ovarian cancer: an international comparison Cheeseman, Sue

30 S4 p. A75-A76
artikel
165 598 Recurrence and survival after laparoscopy versus laparotomy in early stage endometrial cancer: follow-up five years after a randomised trial Reijntjes, Bianca

30 S4 p. A121-A122
artikel
166 447 Recurrence patterns according to time in locally advanced cervical cancer Romero-Mendoza, Abraham

30 S4 p. A19
artikel
167 484 Results of surgical treatment of vulvar cancer using reconstructive plastic surgery Dikareva, Elena

30 S4 p. A106-A107
artikel
168 600 Retroperitoneal metastatic pelvic adamantinoma: a novel location mimicking ovarian malignancy and review of the current literature Smyth, Sarah Louise

30 S4 p. A124
artikel
169 479 Retrospective review of hematological toxicity of chemoradiotherapy in locally advanced cervical cancers Perera, Jananie

30 S4 p. A19-A20
artikel
170 339 Rhabdomyosarcoma of the cervix in teenagers – is fertility preservation a feasible option? Buruiana, Felicia Elena

30 S4 p. A12
artikel
171 530 Risk factors affecting oncological outcomes in vulvar cancer undergoing primary surgery: case series from a tertiary cancer centre Shylasree, T.s.

30 S4 p. A107
artikel
172 94 Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome Mitamura, Takashi

30 S4 p. A55
artikel
173 346 Risk factors for margin positivity in leep Celik, Ozlem

30 S4 p. A12
artikel
174 228 Risk factors for preoperative complications and management with enhanced recovery after primary surgery for women with epithelial ovarian cancer in a single center of china Zhou, Ying

30 S4 p. A57-A58
artikel
175 38 Risk of endometrial cancer among women with benign ovarian tumors – a danish nationwide cohort study Reinholdt, Kristian

30 S4 p. A27-A28
artikel
176 254 Robotic corpus cancer surgery: ten year mortality data from the UK epicentre in guildford Uwins, Christina

30 S4 p. A31
artikel
177 451 Robotic inguinofemoral groin node dissection – modifications to existing robotic technique Shylasree, T.s.

30 S4 p. A104-A105
artikel
178 539 Robotic interval debulking surgery for advanced epithelial ovarian cancer. current challenge or future direction? A systematic review Psomiadou, Victoria

30 S4 p. A88
artikel
179 555 Robotic radical parametrectomy in patients with undiagnosed invasive cervical cancer: a step by step procedure Hajj, Houssein EL

30 S4 p. A23-A24
artikel
180 90 Role of microrna-145 in epithelial ovarian cancer Romero, Carmen

30 S4 p. A54-A55
artikel
181 309 Role of three-dimensional transvaginal ultrasound and diffusion-weighted magnetic resonance imaging for assessment of myometrial invasion in patients with low-risk endometrial cancer Diéguez, Núria Carreras

30 S4 p. A35-A36
artikel
182 385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study Oaknin, Ana

30 S4 p. A39-A40
artikel
183 462 Safety of bevacizumab therapy in elderly patients with ovarian cancer: an experience from the department of gynaecologic oncology in the university hospital centre Zagreb Katić, Kristina

30 S4 p. A83-A84
artikel
184 370 Safety of oncologic surgery without preoperative covid-19 testing in asymptomatic patients Orhan, Nazlı

30 S4 p. A53
artikel
185 592 Sentinel lymph node mapping in early-stage cervical cancer using near-infrared fluorescence imaging: a prospective pilot study Tranoulis, Anastasios

30 S4 p. A115-A116
artikel
186 72 Sentinel lymph node mapping: the answer to the surgical staging dilemma in elderly patients with endometrial cancer Kogan, Liron

30 S4 p. A29
artikel
187 299 Sentinel lymph-node mapping with indocyanine green in endometrial cancer: detection rate and anatomical sites Gedgaudaite, Migle

30 S4 p. A35
artikel
188 549 Sentinel lymph node mapping with indocyanine green in robotic-assisted laparoscopic surgery for early endometrial cancer: a population-based cohort study Tranoulis, Anastasios

30 S4 p. A45-A46
artikel
189 264 Serum markers and cytokines in patients with ovarian cancer, endometriosis or other benign ovarian tumours Nowak, Marek

30 S4 p. A60
artikel
190 144 Sexual function after pelvic radiotherapy: a brief descriptive study in locally advanced cervical cancer patients Sutandar, Yosep

30 S4 p. A95
artikel
191 442 Should we really abandon minimally invasive surgery in early-stage cervical cancer? oncological results of laparoscopically assisted radical vaginal hysterectomy Glickman, Ariel Gustavo

30 S4 p. A17
artikel
192 483 Should we re-stage after positive sentinel node biopsy on endometrial cancer? Gorostidi, Mikel

30 S4 p. A42-A43
artikel
193 419 Signaling pathways related with itgbl1 in ovarian cancer cells Cortez, Alexander J

30 S4 p. A80
artikel
194 604 Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in england: results from the national ovarian cancer feasibility audit pilot Sundar, Sudha S

30 S4 p. A133-A134
artikel
195 523 SOX2 expression in ovarian serous epithelial cancer Conic, Irena

30 S4 p. A87
artikel
196 363 Study of neoadjuvant chemotherapy with a carboplatin and taxol followed by chemoradiation versus chemoradiation for locally advanced cervical cancer Hegazy, Hanady

30 S4 p. A14-A15
artikel
197 235 Succor cone: is it cervical conization a protective maneuver Chacón, Enrique

30 S4 p. A7-A8
artikel
198 163 Supportive function of pegteograstim and pegfilgrastim on chemotherapy-induced neutropenia in ovary cancer patients Kim, Min Kyu

30 S4 p. A90
artikel
199 507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study Gaba, Faiza

30 S4 p. A94
artikel
200 580 Surgical management of gynecologic cancers during the COVID-19 pandemic Shokri, Nazila

30 S4 p. A119
artikel
201 250 Survival implication of pre-treatment imaging tumor dissemination pattern in patients surgically treated for advanced high grade serous ovarian cancer Laios, Alexandros

30 S4 p. A59
artikel
202 271 Survival outcomes of patients with clear cell carcinoma cervix: a single institutional retrospective analysis Sudhakaran, Akhilesh CS

30 S4 p. A8-A9
artikel
203 373 Systematic literature review of efficacy and safety of first-line maintenance therapy trials in advanced ovarian cancer Guy, Holly

30 S4 p. A73-A74
artikel
204 290 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer Rinne, Natasha

30 S4 p. A62
artikel
205 331 Testing prediction accuracy of hdu admission following high grade serous advanced ovarian cancer cytoreductive surgery using machine learning methods Laios, Alexandros

30 S4 p. A111
artikel
206 334 Testing prediction accuracy of ideal and prolonged length of hospital stay following ovarian cancer cytoreduction using machine learning methods Laios, Alexandros

30 S4 p. A110
artikel
207 70 The added value of sentinel node mapping in endometrial cancer Kogan, Liron

30 S4 p. A28
artikel
208 336 The effect of endometriosis on the prognosis of ovarian clear cell carcinoma: the jury is still out Buruiana, Felicia Elena

30 S4 p. A68-A69
artikel
209 495 The effect of other high-risk HPV types on cervical intraepithelial neoplasia and cancer Aker, Seda Sahin

30 S4 p. A21-A22
artikel
210 282 The efficacy of fibrin sealants in reducing the post-operative morbidity after inguino-femoral lymphadenectomy in melanoma and vulval cancer: back to the drawing board? Tranoulis, Anastasios

30 S4 p. A104
artikel
211 305 The evolving role of parp inhibitors in newly diagnosed advanced ovarian cancer: the effect of online education on clinician knowledge, competence and confidence Fisher, Geoff

30 S4 p. A65-A66
artikel
212 39 The oncologic outcome after fertility-sparing hormonal management more than 9 months treatment for early stage endometrioid endometrial cancer Chae, Su Hyun

30 S4 p. A28
artikel
213 119 The positive pelvic lymph nodes in endometrial cancer – histopathological parameters as predictors Mandic, Aljosa

30 S4 p. A30
artikel
214 591 The role of hpv genotypes analysis to prevent overtreatment of high-grade CIN Alessia Salamina, M.

30 S4 p. A129
artikel
215 426 The role of KI-67, P16 and BCL-2 in the management of cervical neoplasia Copos, Anca

30 S4 p. A16
artikel
216 367 The use of real-world evidence from the edinburgh ovarian cancer database to explore a data gap in the prima trial Hollis, Robert L

30 S4 p. A72-A73
artikel
217 215 The utility of a personalised risk calculator in gynae-oncology surgery Jones, Sadie

30 S4 p. A50
artikel
218 40 Training paramedical staff to perform cervical cancer screening with aid of specially designed video based tutorials and comparative evaluation of HPV versus cytology as triage test among via positive women Mishra, Gauravi

30 S4 p. A3
artikel
219 293 Treatment strategies and survival of women with malignant ovarian germ cell tumours – an analysis of the ago-corsett database Hasenburg, Annette

30 S4 p. A62-A63
artikel
220 284 Treatment strategies and survival of women with sex cord stroma cell tumours – an analysis of the ago-corsett database Klar, Maximilian

30 S4 p. A61-A62
artikel
221 88 Tumour molecular features predict endometrial cancer patients‘ survival after different surgical approaches Dai, Yibo

30 S4 p. A29-A30
artikel
222 332 Two-year prognosis estimation of advanced high grade serous ovarian cancer patients using machine learning Laios, Alexandros

30 S4 p. A67-A68
artikel
223 497 Urological complications of cervical cancer treatment : Α retrospective analysis of 420 patients Giannoulopoulos, Dimitrios

30 S4 p. A22
artikel
224 277 Use of preoperative and intraoperative parameters for decision making in ovarian preservation in endometrial adenocarcinoma Batur, Halise Meltem

30 S4 p. A32-A33
artikel
225 112 USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via akt signaling pathway Tellydiao, Wenjing

30 S4 p. A4
artikel
226 612 Vaginal radiofrecuency for the treatment of genital atrophy in patients with oncological history in a public hospital. Life after cancer Berrio, Rocio Garcia

30 S4 p. A129-A130
artikel
227 475 Vulvar cancer: 20 year of experience from a referral center in mexico Rodríguez Rosales, Yuridia Evangelina

30 S4 p. A106
artikel
228 474 Vulvar reconstruction in patients with advanced malignancies Bubliieva, Olha

30 S4 p. A105-A106
artikel
229 241 When MDT interdisciplinarity enhances stringency and professional quality; an analysis of multi-disciplinary team conferences Fog, Sigrid Kasper

30 S4 p. A109-A110
artikel
230 269 Which dietary and everyday life habits affect endometrial cancer recurrence? the machine gives the answer Wersäll, Ofra Castro

30 S4 p. A32
artikel
231 531 12-years results of the Kazakhstan breast cancer screening programme Kaidarova, Dilyara

30 S4 p. A1-A2
artikel
                             231 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland